Qinghai Spring Medicinal Resources Technology Co Ltd (SHG:600381) — Market Cap & Net Worth
Market Cap & Net Worth: Qinghai Spring Medicinal Resources Technology Co Ltd (600381)
Qinghai Spring Medicinal Resources Technology Co Ltd (SHG:600381) has a market capitalization of $308.40 Million (CN¥2.11 Billion) as of May 2, 2026. Listed on the SHG stock exchange, this China-based company holds position #14840 globally and #4588 in its home market, demonstrating a 10.46% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Qinghai Spring Medicinal Resources Technology Co Ltd's stock price CN¥3.59 by its total outstanding shares 587060741 (587.06 Million). Analyse Qinghai Spring Medicinal Resources Techn cash conversion from operations to see how efficiently the company converts income to cash.
Qinghai Spring Medicinal Resources Technology Co Ltd Market Cap History: 2015 to 2026
Qinghai Spring Medicinal Resources Technology Co Ltd's market capitalization history from 2015 to 2026. Data shows change from $1.82 Billion to $308.40 Million (-14.90% CAGR).
Qinghai Spring Medicinal Resources Technology Co Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Qinghai Spring Medicinal Resources Technology Co Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
1.16x
Qinghai Spring Medicinal Resources Technology Co Ltd's market cap is 1.16 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $1.82 Billion | $1.40 Billion | $357.58 Million | 1.30x | 5.10x |
| 2016 | $1.32 Billion | $708.13 Million | $244.96 Million | 1.87x | 5.41x |
| 2017 | $911.46 Million | $471.12 Million | $310.54 Million | 1.93x | 2.94x |
| 2018 | $493.10 Million | $333.02 Million | $68.45 Million | 1.48x | 7.20x |
| 2019 | $463.03 Million | $233.75 Million | $5.81 Million | 1.98x | 79.73x |
| 2020 | $739.65 Million | $124.27 Million | -$319.54 Million | 5.95x | N/A |
| 2021 | $724.18 Million | $127.76 Million | -$248.61 Million | 5.67x | N/A |
| 2022 | $1.06 Billion | $160.18 Million | -$287.55 Million | 6.60x | N/A |
| 2023 | $664.05 Million | $213.88 Million | -$267.87 Million | 3.10x | N/A |
| 2024 | $313.55 Million | $270.26 Million | -$198.77 Million | 1.16x | N/A |
Competitor Companies of 600381 by Market Capitalization
Companies near Qinghai Spring Medicinal Resources Technology Co Ltd in the global market cap rankings as of May 2, 2026.
Key companies related to Qinghai Spring Medicinal Resources Technology Co Ltd by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #499 globally with a market cap of $52.60 Billion USD.
- Zoetis Inc (NYSE:ZTS): Ranked #525 globally with a market cap of $50.31 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #526 globally with a market cap of $50.29 Billion USD ( CN¥343.70 Billion CNY).
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #572 globally with a market cap of $45.88 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #499 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #525 | Zoetis Inc | NYSE:ZTS | $50.31 Billion | $114.16 |
| #526 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $50.29 Billion | CN¥53.88 |
| #572 | GALDERMA GROUP AG | NYSE:GALDY | $45.88 Billion | $42.09 |
Qinghai Spring Medicinal Resources Technology Co Ltd Historical Marketcap From 2015 to 2026
Between 2015 and today, Qinghai Spring Medicinal Resources Technology Co Ltd's market cap moved from $1.82 Billion to $ 308.40 Million, with a yearly change of -14.90%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥308.40 Million | -18.96% |
| 2025 | CN¥380.56 Million | +21.37% |
| 2024 | CN¥313.55 Million | -52.78% |
| 2023 | CN¥664.05 Million | -37.21% |
| 2022 | CN¥1.06 Billion | +46.03% |
| 2021 | CN¥724.18 Million | -2.09% |
| 2020 | CN¥739.65 Million | +59.74% |
| 2019 | CN¥463.03 Million | -6.10% |
| 2018 | CN¥493.10 Million | -45.90% |
| 2017 | CN¥911.46 Million | -31.19% |
| 2016 | CN¥1.32 Billion | -27.33% |
| 2015 | CN¥1.82 Billion | -- |
End of Day Market Cap According to Different Sources
On May 2nd, 2026 the market cap of Qinghai Spring Medicinal Resources Technology Co Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $308.40 Million USD |
| MoneyControl | $308.40 Million USD |
| MarketWatch | $308.40 Million USD |
| marketcap.company | $308.40 Million USD |
| Reuters | $308.40 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Qinghai Spring Medicinal Resources Technology Co Ltd
Qinghai Spring Medicinal Resources Technology Co., Ltd. manufactures and sells alcoholic beverages and health products in China. It operates through two segments, Wine and Beverage Fast-Moving Consumer Goods and Big Health. The Wine and Beverage Fast-Moving Consumer Goods segment focuses on the sales of alcoholic beverages, including the Tinghua series wines. The Big Health segment engages in the… Read more